Recorded live on Thursday, June 24, 2021 • Hosted by AST's Kidney Pancreas Community of Practice (KPCOP)
"Large single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes"
(Am J Transplant. 2020 Dec 22. doi: 10.1111/ajt.16462. Online ahead of print.)
In this article:
Studies have found similar outcomes of Simultaneous Pancreas‐Kidney transplantation (SPKT) in patients with Type 2 (T2D) and Type 1 diabetes (T1D). However, there are scarce data evaluating the association of recipient factors such as age, BMI, or pretransplant insulin requirements with outcomes, thus the criteria for the optimal recipient selection remains unclear. In this study... [the authors found] there was no significant association between BMI or pretransplant insulin requirements with posttransplant diabetes occurrence in either T1D (p = .10, .43, respectively) or T2D (p = .12, .63) patients in the cohort; or with graft failure (T1D: p = .40, .09; T2D: p = .71, .28). These observations suggest a less restricted approach to selective use of SPKT in patients with T2D.
- Jon Odorico, MD • University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
- Ronald Parsons, MD • Emory University School of Medicine, Atlanta, GA